Status:
COMPLETED
Nanoparticles in Nasal Mucosa
Lead Sponsor:
University Hospital Ostrava
Collaborating Sponsors:
VSB - Technical University of Ostrava
Conditions:
Chronic Hypertrophic Rhinosinusitis
Chronic Polypous Rhinosinusitis
Eligibility:
All Genders
19-64 years
Brief Summary
The aim of this prospective study is to evaluate presence and quantity of nano-sized particles and interindividual differences in their distribution and elemental composition in human nasal mucosa obt...
Detailed Description
Samples of nasal mucosa are obtained by mucotomy in general anesthaesia from adult patients with chronic hypertrophic rhinosinusitis. Each tissue sample is divided into 4 parts based on the distance f...
Eligibility Criteria
Inclusion
- chronic hypertrophic rhihosinusitis without polyposis non responsive to conservative treatment for at least six months
- chronic hypertrophic rhihosinusitis with polyposis non responsive to conservative treatment for at least six months
- age between 19 and 64 years of age
- signed informed consent of the patient
- stillborn children born after 28th week of gestation
Exclusion
- \- non-signing of the informed consent
Key Trial Info
Start Date :
September 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2017
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT02270125
Start Date
September 1 2013
End Date
December 1 2017
Last Update
March 30 2018
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Nanotechnology Centre, VSB-Technical University Ostrava
Ostrava, Czech Republic, Czechia, 708 33
2
University Hospital Ostrava
Ostrava, Czech Republic, Czechia, 708 52